Loading publications…
The last 5 uploaded publications
Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study
Syna Miri, Frits R. Rosendaal, Kaan Kavaklı, Peyman Eshghi, Soha Mohammadi Moghaddam, Sara Scardo, Behnaz Habibpanah, Mohsen Saleh Elalfy, Susan Halimeh, Gabriella Nicolò, Dilek Gürlek Gökçebay, Namık Yaşar Özbek, Tıraje Celkan, Ahmad Mohammadi, Mehran Karimi, Amin Shahsavani, Barış Yılmaz, Canan Albayrak, Burçak Tatlı Güneş, Zühre Kaya, Yılmaz Ay, Sinan Akbayram, Nazan Sarper, Pier Mannuccio Mannucci, Flora Peyvandi (2024). Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study. Research and Practice in Thrombosis and Haemostasis, 8(8), pp. 102595-102595, DOI: 10.1016/j.rpth.2024.102595.
Article126 days agoIgG subclasses as biomarkers for persistence of factor VIII inhibitors in previously untreated patients with severe haemophilia A
Flora Peyvandi, Syna Miri, Paolo Bucciarelli, Carla Valsecchi, Lucia Schiavone, Marco Boscarino, Roberta Palla, Pier Mannuccio Mannucci, Frits R. Rosendaal (2020). IgG subclasses as biomarkers for persistence of factor VIII inhibitors in previously untreated patients with severe haemophilia A. British Journal of Haematology, 192(3), pp. 621-625, DOI: 10.1111/bjh.17249.
Article126 days ago